Home > List All Publishers > Venture Planning Group

Venture Planning Group

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:

Market Intelligence Surveys
Opportunities Analyses
New Technology/Product Assessments
Acquisitions/Joint Venture Evaluations

During the course of numerous proprietary single-client consulting assignments and over 10

0 multi-client studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

List of reports from Venture Planning Group

2013 Analysis of the Occult Blood Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ... \| read more...	$4,350.00
2013 Analysis of the PSA Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ... \| read more...	$4,350.00
2013 Analysis of the Cell Surface Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This ... \| read more...	$5,350.00
2013 Analysis of the Immunoprotein Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, ... \| read more...	$8,500.00
2013 Analysis of the Therapeutic Drug Monitoring Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent ... \| read more...	$8,500.00
2013 Analysis of the Alpha-2 Antiplasmin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... automated instrumentation. Coagulation testing in general, and Alpha-2 Antiplasmin testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will ... \| read more...	$4,350.00
2013 Analysis of the Factor Assay Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will ... \| read more...	$5,350.00
2013 Analysis of the Fibrinogen Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... automated instrumentation. Coagulation testing in general, and Fibrinogen testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate ... \| read more...	$4,350.00
2013 Analysis of the Heparin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... automated instrumentation. Coagulation testing in general, and Heparin testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate ... \| read more...	$4,350.00
2013 Analysis of the Proteins C and S Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... automated instrumentation. Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological ... \| read more...	$4,350.00
2013 Analysis of the CMV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Blood Banks - Physician Offices - Public Health Labs For each ... \| read more...	$5,450.00
2013 Analysis of the CoxsackievirusTesting Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs Also, the report examines the ... \| read more...	$4,350.00
2013 Analysis of the Herpes Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets: - Hospitals - Commercial/Private Labs - Physician Offices - ... \| read more...	$5,450.00
2013 Analysis of the HIV/AIDS Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5- and ... \| read more...	$5,450.00
2013 Analysis of the Adenovirus Diagnostics Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and ... \| read more...	$4,350.00
2013 Analysis of the Gonorrhea Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| read more...	$4,350.00
2013 Analysis of the Influenza Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| read more...	$4,350.00
2013 Analysis of the Lime Disease Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs -Physician Offices - Public Health Labs In addition to test ... \| read more...	$4,350.00
2013 Analysis of the Malaria Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs Also, the report examines the ... \| read more...	$4,350.00
2013 Analysis of the Measles Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume ... \| read more...	$4,350.00
2013 Analysis of the Mononucleosis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| read more...	$4,350.00
2013 Analysis of the Mycoplasma Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| read more...	$4,350.00
2013 Analysis of the Pseudomonas Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs Also, the report examines the ... \| read more...	$4,350.00
2013 Analysis of the Rabies Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume ... \| read more...	$4,350.00
2013 Analysis of the Respiratory Syncytial Virus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: -Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each ... \| read more...	$4,350.00

< prev 1 2 3 4 5 6 7 8 9 10 next >